Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label

Comparison of the safety and immunogenicity of an investigational

Prevention and Control of Meningococcal Disease

Microorganisms, Free Full-Text

Vaccines, Free Full-Text

Full article: Immunogenicity and safety of a booster dose of a

Core Concepts - Immunizations in Adults - Basic HIV Primary Care

Meningococcal Vaccine Toolkit

PDF) Immunogenicity and safety of a booster dose of a quadrivalent

Structured Benefit-Risk Assessment of a New Quadrivalent

Immunogenicity and safety of a quadrivalent meningococcal tetanus

PDF) Immunogenicity and safety of MenACWY-TT, a quadrivalent